New Findings from First Affiliated Hospital Yields New Data on Lung Cancer
By a News Reporter-Staff News Editor at Gene Therapy Weekly -- Investigators publish new report on Lung Cancer. According to news originating from Nanjing, People's Republic of China, by NewsRx correspondents, research stated, "Klotho was first identified in 1997 and has been considered as an anti-aging gene. Emerging evidence demonstrates that klotho has a close relationship with cancers, including lung cancer, breast cancer, etc, by inhibiting the proliferation and promoting apoptosis of cancer cells."
Our news journalists obtained a quote from the research from First Affiliated Hospital, "Cisplatin has been the most widely used drug in the first-line chemotherapy. However, the increase in cisplatin-resistant cancer cells has become a major obstacle in clinical management of cancers. In our study, we for the first time demonstrated that klotho could attenuate the resistance of lung cancer to cisplatin based chemotherapy and the apoptosis of the resistant cells with klotho overexpression was markedly increased. However, klotho knockdown cells showed enhanced resistance to chemotherapy. Further analysis showed that inhibition of PI3K/Akt pathway with specific inhibitor (LY294002) attenuated the promotive effects on cancer growth following interfering with klotho shRNA. Moreover, we demonstrated that klotho modulated the resistance to cisplatin in a xenograft nude mice model."
According to the news editors, the research concluded: "These observations suggested that klotho could improve the resistance of lung cancer cells to chemotherapy and may serve as a potential target for the gene therapy of lung cancers resistant to cisplatin based chemotherapy."
For more information on this research see: Klotho sensitizes human lung cancer cell line to cisplatin via PI3k/Akt pathway. Plos One, 2013;8(2):e57391. (Public Library of Science - www.plos.org; Plos One - www.plosone.org)
The news correspondents report that additional information may be obtained from Y. Wang, Dept. of Geriatrics, The First Affiliated Hospital of Nanjing Medical University, Nanjing, People's Taiwan (see also Lung Cancer).
Keywords for this news article include: Asia, Antineoplastics, Biotechnology, Pharmaceuticals, Drugs, Nanjing, Oncology, Cisplatin, Lung Cancer, Chemotherapy, Bioengineering, Lung Neoplasms, Alkylating Agents, Chlorine Compounds, Nitrogen Compounds, Platinum Compounds, Cancer Gene Therapy, People's Republic of China.
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2013, NewsRx LLC
To see more of the NewsRx.com, or to subscribe, go to http://www.newsrx.com .